GlassScriptPhysician profile
Kirk J Tiemann
NPI 1427249564
$3,887.96
in general payments reported to CMS, 2019-2025
40 companies · $331 in 2025
The $331 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $307 · 2021: $1,015 · 2022: $526 · 2023: $850 · 2024: $425 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,605.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,294.49 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $603.78 | 2019-2024 | Trelegy Ellipta, Shingrix |
| Exeltis, USA INC. | $311.45 | 2023 | Slynd |
| Horizon Therapeutics Plc | $164.03 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $142.76 | 2020-2021 | |
| Lilly USA, LLC | $99.13 | 2021-2023 | Jardiance, Emgality |
| Abbvie INC. | $86.19 | 2021 | |
| Amgen INC. | $79.66 | 2022-2025 | Otezla, Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.31 | 2019-2022 | |
| Amarin Pharma, INC. | $71.41 | 2019-2022 | |
| Dynasplint Systems INC. | $69.25 | 2021 | |
| Eisai INC. | $64.94 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $64.86 | 2020-2022 | |
| Depuy Synthes Sales INC. | $59.83 | 2021-2024 | Monovisc |
| Novo Nordisk INC | $59.30 | 2019-2024 | Rybelsus, Ozempic |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Tiemann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.